Antiphospholipid syndrome; its implication in cardiovascular diseases: a review
Open Access
- 3 November 2010
- journal article
- review article
- Published by Springer Nature in Journal of Cardiothoracic Surgery
- Vol. 5 (1) , 101
Abstract
Antiphospholipid syndrome (APLS) is a rare syndrome mainly characterized by several hyper-coagulable complications and therefore, implicated in the operated cardiac surgery patient. APLS comprises clinical features such as arterial or venous thromboses, valve disease, coronary artery disease, intracardiac thrombus formation, pulmonary hypertension and dilated cardiomyopathy. The most commonly affected valve is the mitral, followed by the aortic and tricuspid valve. For APLS diagnosis essential is the detection of so-called antiphospholipid antibodies (aPL) as anticardiolipin antibodies (aCL) or lupus anticoagulant (LA). Minor alterations in the anticoagulation, infection, and surgical stress may trigger widespread thrombosis. The incidence of thrombosis is highest during the following perioperative periods: preoperatively during the withdrawal of warfarin, postoperatively during the period of hypercoagulability despite warfarin or heparin therapy, or postoperatively before adequate anticoagulation achievement. Cardiac valvular pathology includes irregular thickening of the valve leaflets due to deposition of immune complexes that may lead to vegetations and valve dysfunction; a significant risk factor for stroke. Patients with APLS are at increased risk for thrombosis and adequate anticoagulation is of vital importance during cardiopulmonary bypass (CPB). A successful outcome requires multidisciplinary management in order to prevent thrombotic or bleeding complications and to manage perioperative anticoagulation. More work and reporting on anticoagulation management and adjuvant therapy in patients with APLS during extracorporeal circulation are necessary.Keywords
This publication has 94 references indexed in Scilit:
- Heart valve surgery in patients with the antiphospholipid syndrome: analysis of a series of nine casesEuropean Journal of Cardio-Thoracic Surgery, 2010
- Antiphospholipid Syndrome: Intraoperative and Postoperative Anticoagulation in Cardiac SurgeryJournal of Cardiothoracic and Vascular Anesthesia, 2008
- Assessment of Cardiac Structure and Left Atrial Appendage Functions in Primary Antiphospholipid SyndromeStroke, 2005
- Use of bivalirudin, a direct thrombin inhibitor, and its reversal with modified ultrafiltration during heart transplantation in a patient with heparin-induced thrombocytopeniaThe Journal of Heart and Lung Transplantation, 2005
- Effectiveness of bivalirudin as a replacement for heparin during cardiopulmonary bypass in patients undergoing coronary artery bypass graftingThe American Journal of Cardiology, 2004
- Catastrophic Antiphospholipid SyndromeMedicine, 2001
- Tissue Factor Pathway and the Antiphospholipid SyndromeJournal of Autoimmunity, 2000
- Antiphospholipid Syndrome and Perioperative Hemostatic Management of Cardiac Valvular SurgeryMayo Clinic Proceedings, 2000
- Successful thrombolytic therapy for acute myocardial infarction in a patient with the antiphospholipid antibody syndromeAmerican Heart Journal, 1991
- Antiphospholipid antibodies: more than just a disease marker?Immunology Today, 1990